Add to Favorites Newsroom RSS Share
La Jolla, CA USA

Our News on Newswise

New Painkillers Reduce Overdose Risk


The research shows that a range of compounds can deliver pain-blocking potency without affecting respiration.
15-Nov-2017 3:50 PM EST Add to Favorites

A Structural Clue to Attacking Malaria’s ‘Achilles Heel’

New research could boost the development of a more potent vaccine against the global killer.
15-Nov-2017 5:05 PM EST Add to Favorites

Potential New Autism Drug Shows Promise in Mice

NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder (ASD).
11-Nov-2017 5:05 AM EST Add to Favorites

Ozanimod Successful in Clinical Trials for Multiple Sclerosis

Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod. Ozanimod was invented by scientists at The Scripps Research Institute (TSRI).
9-Nov-2017 4:05 PM EST Add to Favorites

Scientists Find Potential “Missing Link” in Chemistry That Led to Life on Earth


Chemists at The Scripps Research Institute (TSRI) have found a compound that may have been a crucial factor in the origins of life on Earth.
3-Nov-2017 3:30 PM EDT Add to Favorites

How Flu Shot Manufacturing Forces Influenza to Mutate


Egg-based production causes virus to target bird cells, making vaccine less effective.
30-Oct-2017 12:05 PM EDT Add to Favorites

New ResearchKit App Looks at How Genetic Risk Influences Heart Health Decisions


The MyGeneRank app allows individuals with genetic data from 23andMe to obtain an estimated genetic risk score for coronary artery disease.
25-Oct-2017 12:05 PM EDT Add to Favorites

New Study: ‘Double Decker’ Antibody Technology Fights Cancer


Scientists from the Florida campus of The Scripps Research Institute have created a new class of antibody-drug conjugates for cancer therapy.
25-Oct-2017 5:05 AM EDT Add to Favorites

Our YouTube Videos

Chat now!